Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT). (UBCT)
The investigators are doing this study to find out if a new kind of breast imaging (called upright dedicated breast CT or UBCT) can help doctors to see the small structures in breast tissue more clearly in 3-D and without overlap.
The breast imaging device that will be used in this study (UBCT) is not FDA-approved, so this is a research study. The machine has been designed to remove mammography-like breast compression and use radiation dose comparable to mammography. The breast CT device will take multiple x-ray pictures of the subjects breast in approximately 20 seconds and create a 3-D image of the breast. It does not compress or squish the breast like a mammogram.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Michele N Galvan, R.T.
- 电话号码:520-626-2279
- 邮箱:mngalvan@arizona.edu
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
For the screening cohort, the inclusion criteria are, women:
- (1) who were 40 years of age or older (typical screening age range), and,
- (2) who were asymptomatic, and,
- (3) who underwent or scheduled to undergo a standard-of-care 2-view bilateral digital breast tomosynthesis screening exam.
For the diagnostic cohort, the inclusion criteria are, women:
- (1) who were 40 years of age or older, and,
- (2) who underwent a standard-of-care 2-view bilateral digital breast tomosynthesis exam, and,
- (3) who were assigned BI-RADS category 4 or 5 after diagnostic work-up and are scheduled for biopsy.
Exclusion Criteria:
- Males
- Women less than 40 years old
- pregnant or lactating women
- women with physical limitations (e.g., kyphosis) that may prohibit UBCT exam
- women who have received radiation treatments to the thorax
- women who have participated in a prior breast clinical trial that gave additional radiation dose
- women who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as tuberculosis, and severe scoliosis.
学习计划
研究是如何设计的?
设计细节
- 主要用途:诊断
- 分配:非随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Screening cohort
Women who undergo breast cancer screening using mammography and/or digital breast tomosynthesis.
|
This study investigates the feasibility of an upright, dedicated breast CT (UBCT) for breast cancer detection.
其他名称:
|
|
实验性的:Diagnostic cohort
Women who have suspicious finding(s) that require biopsy.
|
This study investigates the feasibility of an upright, dedicated breast CT (UBCT) for breast cancer detection.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Feasibility of UBCT
大体时间:From enrollment to end of study in approximately 6 months.
|
The proportion of participants who successfully complete the imaging exam using upright, dedicated breast CT (UBCT).
|
From enrollment to end of study in approximately 6 months.
|
合作者和调查者
调查人员
- 首席研究员:Srinivasan Vedantham, PhD、University of Arizona
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 1904498647
- R01CA241709 (美国 NIH 拨款/合同)
- IRG 18-161-40 (其他赠款/资助编号:American Cancer Society)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.